AMPK-dependent and independent effects of AICAR and compound C on T-cell responses

Oncotarget. 2016 Jun 7;7(23):33783-95. doi: 10.18632/oncotarget.9277.

Abstract

As a master metabolic sensor, AMP-activated protein kinase (AMPK) is involved in different fundamental cellular processes. Regulation of AMPK activity either by agonists (e.g., AICAR) or by antagonists (e.g., Compound C) has been widely employed to study the physiological functions of AMPK. However, mounting evidence indicates AMPK-independent effects for these chemicals and how they regulate immune cell functions remains largely unknown. Herein, using T cells from AMPK conditional knockout mice and their wild type littermates, we demonstrate that AICAR and Compound C can, indeed, activate or inhibit AMPK activity in T cells, respectively. Specifically, AICAR inhibits, but Compound C promotes, Ca2+-induced T cell death in an AMPK-dependent manner. In contrast, our data also demonstrate that AICAR and Compound C inhibit T cell activation and cytokine production in an AMPK-independent manner. Moreover, we find that the AMPK-independent activity of AICAR and Compound Cis mediated via the mTOR signaling pathway in activated T cells. Our results not only reveal the critical role of AMPK in regulating T cell survival and function, but also demonstrate AMPK-dependent and independent rolesof AICAR/Compound C in regulating T cell responses, thus suggesting a context-dependent effect of these "AMPK regulators".

Keywords: AMPK; Immune response; Immunity; Immunology and Microbiology Section; T cell responses.

MeSH terms

  • AMP-Activated Protein Kinases / antagonists & inhibitors
  • AMP-Activated Protein Kinases / deficiency
  • AMP-Activated Protein Kinases / genetics
  • AMP-Activated Protein Kinases / metabolism*
  • Aminoimidazole Carboxamide / analogs & derivatives*
  • Aminoimidazole Carboxamide / pharmacology
  • Animals
  • Calcium Signaling / drug effects
  • Cell Death / drug effects
  • Cells, Cultured
  • Cytokines / metabolism
  • Dose-Response Relationship, Drug
  • Enzyme Activation
  • Enzyme Activators / pharmacology*
  • Genotype
  • Immunologic Factors / pharmacology*
  • Lymphocyte Activation / drug effects*
  • Mice, Knockout
  • Phenotype
  • Protein Kinase Inhibitors / pharmacology*
  • Pyrazoles / pharmacology*
  • Pyrimidines / pharmacology*
  • Ribonucleosides / pharmacology*
  • T-Lymphocytes / drug effects*
  • T-Lymphocytes / enzymology
  • T-Lymphocytes / immunology
  • T-Lymphocytes / pathology
  • TOR Serine-Threonine Kinases / metabolism

Substances

  • Cytokines
  • Enzyme Activators
  • Immunologic Factors
  • Protein Kinase Inhibitors
  • Pyrazoles
  • Pyrimidines
  • Ribonucleosides
  • dorsomorphin
  • Aminoimidazole Carboxamide
  • acadesine
  • mTOR protein, mouse
  • AMPK alpha1 subunit, mouse
  • TOR Serine-Threonine Kinases
  • AMP-Activated Protein Kinases